已核实 DOI PubMed 相关产品: 12

Oxidized Chitosan-Tobramycin (OCS-TOB) Submicro-Fibers for Biomedical Applications

Journal 2022 · IF 6.525 · 14(6): 1197 · 发表于 2022 年 6 月 3 日
作者: Zhen Li,Shunqi Mei,Yajie Dong,Fenghua She,Chengpeng Li,Yongzhen Li,Lingxue Kong
阅读全文 在 PubMed 查看

摘要

Chitosan (CS) is a biodegradable, biocompatible, and non-toxic natural amino-poly-saccharide with antibacterial ability, owing to its positively charged amino groups. However, the low charge density leads to poor antibacterial efficiency which cannot meet the biomedical application requirements. In this study, Tobramycin (TOB) was grafted onto the backbone of oxidized chitosan (OCS) to synthesize oxidized chitosan-tobramycin (OCS-TOB). FTIR,1H NMR and elemental analysis results demonstrated that OCS-TOB was successfully synthesized. OCS-TOB/PEO composite fibrous materials were produced by a self-made centrifugal spinning machine. In vitro experiments showed that cells proliferated on the submicro-fibrous OCS-TOB/PEO of appropriate concentration, and the antibacterial ability of OCS-TOB was much improved, compared with pristine CS. The results demonstrated that OCS-TOB/PEO nanofibrous materials could potentially be used for biomedical applications.Keywords:chitosan;tobramycin;centrifugal spinning;submicro-fibers;biomedical application

本研究中使用的阿拉丁产品

12 款产品在本文中被引用